Tobira appoints Antoun Nabhan
This article was originally published in Scrip
Executive Summary
Tobira Therapeutics has appointed Mr Antoun Nabhan as Vice President, Business Development. Reporting to company president and CEO Andrew Hindman, Dr Nabhan will be responsible for the HIV treatment-focused company's strategic transactions and partnering activities, as well as certain operating activities. Mr Nabhan joins Tobira from Onyx Pharmaceuticals, where he held a number of positions in corporate development and strategy, including a key role in the company's acquisition of Proteolix. Prior to Onyx, Mr Nabhan was co-founder, CFO and VP Operations at Presidio Pharmaceuticals, a principal at VC Sagamore Biosciences, and VP Business Development & Finance for Intellico Inc, systems biology company acquired by Genstruct Inc.